Last reviewed · How we verify
Restylane line of injectables — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Restylane line of injectables (Restylane line of injectables) — Erevna Innovations Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Restylane line of injectables TARGET | Restylane line of injectables | Erevna Innovations Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Restylane line of injectables CI watch — RSS
- Restylane line of injectables CI watch — Atom
- Restylane line of injectables CI watch — JSON
- Restylane line of injectables alone — RSS
Cite this brief
Drug Landscape (2026). Restylane line of injectables — Competitive Intelligence Brief. https://druglandscape.com/ci/restylane-line-of-injectables. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab